1. Development of artemisinin compounds for cancer treatment
   Henry C. Lai et al, 2013, Investigational New Drugs CrossRef
2. Artemisinin as an anticancer drug: Recent advances in target profiling and mechanisms of action
   Yin Kwan Wong et al, 2017, Medicinal Research Reviews CrossRef
3. Oxidative phosphorylation activation is an important characteristic of DOX resistance in hepatocellular carcinoma cells
   Li Wu et al, 2018, Cell Communication and Signaling CrossRef
4. DJ-1 mediates the resistance of cancer cells to dihydroartemisinin through reactive oxygen species removal
   Hong Zhu et al, 2014, Free Radical Biology and Medicine CrossRef
5. Activation of Mitochondria-Driven Pathways by Artemisinin and Its Derivatives
   Thomas Efferth, 2014, Mitochondria: The Anti- cancer Target for the Third Millennium CrossRef
6. Pharmacological Potentials of Artemisinin and Related Sesquiterpene Lactones: Recent Advances and Trends
   María José Abad Martínez et al, 2014, Artemisia annua - Pharmacology and Biotechnology CrossRef
7. A comprehensive overview of Artemisinin and its derivatives as anticancer agents
   Zi-wei Zeng et al, 2023, European Journal of Medicinal Chemistry CrossRef
8. Proteomic Contributions to Medicinal Plant Research: From Plant Metabolism to Pharmacological Action
   Akiko Hashiguchi et al, 2017, Proteomes CrossRef
9. Antiproliferative activity and phenotypic modification induced by selected Peruvian medicinal plants on human hepatocellular carcinoma Hep3B cells
   Maëlle Carraz et al, 2015, Journal of Ethnopharmacology CrossRef
10. Dihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells
    Guiqi Qin et al, 2015, Apoptosis CrossRef